Background: In recent years, patient-reported outcomes (PROs) have received increasing prominence in cardio-vascular research and clinical care. An understanding of the variability and global experience of PROs in adults with congenital heart disease (CHD), however, is still lacking. Moreover, information on epidemiological characteristics and the frailty phenotype of older adults with CHD is minimal. The APPROACH-IS II study was established to address these knowledge gaps. This paper presents the design and methodology of APPROACH-IS II.Methods/design: APPROACH-IS II is a cross-sectional global multicentric study that includes Part 1 (assessing PROs) and Part 2 (investigating the frailty phenotype of older adults). With 53 participating ce...
OBJECTIVE: To derive cluster analysis-based groupings for adults with congenital heart disease (ACHD...
Aim: Due to improved therapy in childhood, many patients with congenital heart disease reach adultho...
Lu CW, Wang JK, Yang HL, Kovacs AH, Luyckx K, Ruperti-Repilado FJ, Van De Bruaene A, Enomoto J, Slum...
Background: In recent years, patient-reported outcomes (PROs) have received increasing prominence in...
Background: In recent years, patient-reported outcomes (PROs) have received increasing prominence in...
Background: In recent years, patient-reported outcomes (PROs) have received increasing prominence in...
Background: Data on patient-reported outcomes (PROs) in adults with congenital heart disease (CHD) a...
Background Data on patient-reported outcomes (PROs) in adults with congenital heart disease (CHD) ar...
Data on patient-reported outcomes (PROs) in adults with congenital heart disease (CHD) are inconsist...
BACKGROUND: Data on patient-reported outcomes (PROs) in adults with congenital heart disease (CHD) a...
Patient-reported outcomes (PROs) are “any outcome based on data provided by patients or patient prox...
Aims: Congenital heart disease (CHD) is the most common congenital malformation. Despite the worldwi...
Aims: Congenital heart disease (CHD) is the most common congenital malformation. Despite the worldwi...
In this international study, we (1) compared patient-reported outcomes (PROs) in adults with congeni...
AIMS Geographical differences in patient-reported outcomes (PROs) of adults with congenital heart...
OBJECTIVE: To derive cluster analysis-based groupings for adults with congenital heart disease (ACHD...
Aim: Due to improved therapy in childhood, many patients with congenital heart disease reach adultho...
Lu CW, Wang JK, Yang HL, Kovacs AH, Luyckx K, Ruperti-Repilado FJ, Van De Bruaene A, Enomoto J, Slum...
Background: In recent years, patient-reported outcomes (PROs) have received increasing prominence in...
Background: In recent years, patient-reported outcomes (PROs) have received increasing prominence in...
Background: In recent years, patient-reported outcomes (PROs) have received increasing prominence in...
Background: Data on patient-reported outcomes (PROs) in adults with congenital heart disease (CHD) a...
Background Data on patient-reported outcomes (PROs) in adults with congenital heart disease (CHD) ar...
Data on patient-reported outcomes (PROs) in adults with congenital heart disease (CHD) are inconsist...
BACKGROUND: Data on patient-reported outcomes (PROs) in adults with congenital heart disease (CHD) a...
Patient-reported outcomes (PROs) are “any outcome based on data provided by patients or patient prox...
Aims: Congenital heart disease (CHD) is the most common congenital malformation. Despite the worldwi...
Aims: Congenital heart disease (CHD) is the most common congenital malformation. Despite the worldwi...
In this international study, we (1) compared patient-reported outcomes (PROs) in adults with congeni...
AIMS Geographical differences in patient-reported outcomes (PROs) of adults with congenital heart...
OBJECTIVE: To derive cluster analysis-based groupings for adults with congenital heart disease (ACHD...
Aim: Due to improved therapy in childhood, many patients with congenital heart disease reach adultho...
Lu CW, Wang JK, Yang HL, Kovacs AH, Luyckx K, Ruperti-Repilado FJ, Van De Bruaene A, Enomoto J, Slum...